News
Important Only
BRIEF-Palvella Therapeutics To Expand Phase 3 Selva Clinical Trial Of Qtorin™ 3.9% Rapamycin Anhydrous Gel (Qtorin™ Rapamycin)
Feb 10 (Reuters) - Palvella Therapeutics PVLA.O:PALVELLA THERAPEUTICS TO EXPAND PHASE 3 SELVA CLINICAL TRIAL OF QTORIN™ 3.9% RAPAMYCIN ANHYDROUS GEL (QTORIN™ RAPAMYCIN) FOR THE TREATMENT OF MICROCYSTIC LYMPHATIC MALFORMATIONS TO INCLUDE THE YOUNGER PEDIATRIC POPULATION, CHILDREN 3 TO 5 YEARS OLDPALV...Reuters
Mon, Feb 10
BRIEF-Sinclair Announces 99.1% Early Participation And Receipt Of Requisite Notes Consents In Private Debt Exchange Offer And Consent Solicitation Of Sinclair Television Group
Feb 10 (Reuters) - Sinclair SBGI.O:SINCLAIR ANNOUNCES 99.1% EARLY PARTICIPATION AND RECEIPT OF REQUISITE NOTES CONSENTS IN PRIVATE DEBT EXCHANGE OFFER AND CONSENT SOLICITATION OF SINCLAIR TELEVISION GROUPSource text: ID:nBw3NSrj6aFurther company coverage: SBGI.OReuters
Mon, Feb 10
MDA Space expands contract with Globalstar to C$1.1 billion for next-gen satellites
Feb 10 (Reuters) - Canadian MDA Space MDA.TO said on Monday that it has expanded its contract with Globalstar GSAT.A to develop the next generation of low Earth orbit satellites, bringing the total contract value to about C$1.1 billion ($767.19 million).MDA Space will manufacture more than 50 advanc...Reuters
Mon, Feb 10
Japan's Softbank Group seen booking $1.5 billion quarterly profit
Analysts divided on AI investments' impact on SoftBank's profitsSwiggy's market debut may boost SoftBank's unlisted tech portfolio valueSoftBank's AI investments may require asset sales or increase debtBy Anton BridgeTOKYO, Feb 10 (Reuters) - Japan's SoftBank Group 9984.T is ...Reuters
Mon, Feb 10
BRIEF-Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Feb 10 (Reuters) - Ocean Biomedical OCEA.O:OCEAN BIOMEDICAL ANNOUNCES BREAKTHROUGH FINDINGS IN EGFR-MUTANT LUNG CANCER AND PLANS FOR FDA ALIGNMENT ON NEXT-STAGE DEVELOPMENTOCEAN BIOMEDICAL- TO INITIATE PRECLINICAL STUDIES TO ADVANCE IMMUNOTHERAPY PROGRAM & TO ENGAGE WITH FDA FOR FIRST-IN-HUMAN T...Reuters
Mon, Feb 10
South African party accuses white group of treason over Trump attack
MK party says AfriForum spread lies that swayed Trump US president attacked law to redistribute white-owned landAfriForum CEO says treason accusation is absurdBy Wendell Roelf CAPE TOWN, Feb 10 (Reuters) - The party of South Africa's ex-president Jacob Zuma on Monday filed a treason complaint...Reuters
Mon, Feb 10
Trump's foreign aid cuts 'catastrophic,' says global Catholic charity arm
Caritas Internationalis criticizes Trump's foreign aid cuts as catastrophicCuts affect USAID, impacting millions in developing countriesCatholic Relief Services and U.S. Bishops face layoffs due to funding cutsBy Joshua McElwee VATICAN CITY, Feb 10 (Reuters) - The Roman Catholic Church's ...Reuters
Mon, Feb 10
BRIEF-Latin Metals And Vale Agree Data Purchase On Peru's Para Copper Project
Feb 10 (Reuters) - Latin Metals LMS.V:LATIN METALS AND VALE AGREE DATA PURCHASE ON PARA COPPER PROJECT, PERULATIN METALS- GRANTED TIME-LIMITED RIGHT OF FIRST OFFER TO VALE, WHICH WILL BECOME VALID ON COMPLETION OF PREFEASIBILITY STUDY & EXPIRE IN 2035Source text: ID:nGNX6NGkR6Further company cov...Reuters
Mon, Feb 10
BRIEF-Evome Medical Technologies Announces Debt Reduction And Restructuring
Feb 10 (Reuters) - Evome Medical Technologies EVMT.V:EVOME MEDICAL TECHNOLOGIES ANNOUNCES SIGNIFICANT DEBT REDUCTION AND RESTRUCTURINGEVOME MEDICAL TECHNOLOGIES INC - MIRION REMOVES RESTRICTIONS ON USE OF FINANCING PROCEEDSEVOME MEDICAL TECHNOLOGIES INC - MIRION RELAXES RESTRICTIONS ON EVOME'S M...Reuters
Mon, Feb 10
BRIEF-Thomson Reuters Launches Second Corporate VC Fund Valued At $150 Mln
Feb 10 (Reuters) - Thomson Reuters TRI.TO, TRI.N:THOMSON REUTERS ANNOUNCES LAUNCH OF ITS SECOND CORPORATE VENTURE CAPITAL FUND, VALUED AT $150 MILLIONSECOND FUND TO FOCUS ON EARLY-STAGE COS IN LEGAL TECH, TAX & ACCOUNTING, FINTECH, RISK FRAUD & COMPLIANCE, NEWS & MEDIASECOND FUND WILL TA...Reuters
Mon, Feb 10
BRIEF-Tempest Granted Fast Track Designation From The U.S. Food And Drug Administration For Amezalpat
Feb 10 (Reuters) - Tempest Therapeutics TPST.O:TEMPEST GRANTED FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION FOR AMEZALPAT TO TREAT PATIENTS WITH HEPATOCELLULAR CARCINOMASource text: ID:nGNX5h7lh8Further company coverage: TPST.OReuters
Mon, Feb 10
BRIEF-Verde Collaborates With Ergon To Produce Emulsion For Low-Carbon Road Surface Materials
Feb 10 (Reuters) - Verde Resources VRDR.PK:VERDE COLLABORATES WITH ERGON TO PRODUCE INNOVATIVE EMULSION FOR LOW-CARBON ROAD SURFACE MATERIALSSource text: ID:nPn5r68lMaFurther company coverage: VRDR.PKReuters
Mon, Feb 10
BRIEF-Automotive Properties REIT To Acquire Tesla Collision Center
Feb 10 (Reuters) - Automotive Properties Real Estate Investment Trust APR_u.TO:AUTOMOTIVE PROPERTIES REIT ANNOUNCES AGREEMENT TO ACQUIRE TESLA COLLISION CENTER PROPERTY IN COLUMBUS, OHIO FOR A PURCHASE PRICE OF US$17.8 MILLIONAUTOMOTIVE PROPERTIES REAL ESTATE INVESTMENT TRUST - ACQUISITION EXPECTED ...Reuters
Mon, Feb 10
BRIEF-Energy Transfer And Cloudburst Sign Agreement For Natural Gas Supply
Feb 10 (Reuters) - Energy Transfer ET.N:ENERGY TRANSFER AND CLOUDBURST SIGN AGREEMENT FOR NATURAL GAS SUPPLY TO DATA CENTER PROJECT IN CENTRAL TEXASENERGY TRANSFER LP: GAS SUPPLY EXPECTED TO GENERATE UP TO 1.2 GIGAWATTS OF DIRECT POWER TO AI-FOCUSED DATA CENTERENERGY TRANSFER LP - CLOUDBURST EXPECTS...Reuters
Mon, Feb 10
China's BYD in advanced talks to form pool in Europe over carbon credits
Adds context in paragraphs 5-8 TURIN, Feb 10 (Reuters) - Chinese EV giant BYD 002594.SZ is in talks to form a pool with European automakers and sell them carbon credits to help them avoid hefty European Union fines on 2025 emissions, a BYD representative said on Monday."We're in talks, we...Reuters
Mon, Feb 10
